Form D · Other Technology
Kaden Health, Inc.
New York, NY · CIK 0001830272
Offering snapshot reported Nov 12, 2020 · SEC filing
- Reported sold
- $19.1M Offering amount: $19.1M
- Investors reported
- 34 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Oct 27, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 12, 2020 | Initial | $19,078,165 | No comparison | 34 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $450K
- Finders' fees
- $0
- Form D file number
- 021-380256
Source: Form D, filed Nov 12, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Matt Bemis | Executive |
| Wahida Bhuyan | Executive |
| Ray Emirzian | Executive |
| David Henderson | Director, Executive |
| Steven Kessler | Director, Executive |
| Michael Lardieri | Executive |
| Aran Ron | Director, Executive |
| Jonathan Ungar | Director |
Issuer details
Industry: Other Technology (See others in industry)
Address:
205 East 42 Nd Street 15 Th Floor
New York, NY, 10017
New York, NY, 10017